Comments

Purple Biotech Stock Price, Quotes and Forecasts

Q: What sector and industry does Purple Biotech (PPBT) operate in?

Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

PPBTNASDAQ

Logo brought to you by Benzinga Data

Perks Trade with Public

Purple Biotech (PPBT) Forecast

News Earnings Purple Biotech (PPBT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Purple Biotech Stock Price, Quotes and Forecasts | NASDAQ:PPBT | Benzinga

Explore Purple Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PPBT.

Open	$2.40
Close	-
Volume / Avg.	4.74K / 109.24K
Day Range	$2.36 - $2.49
52 Wk Range	2.00 - 13.95
Market Cap	$6.59M
P/E Ratio	0.01
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.71%
Days to Cover	5.65

Recent News

Why Purple Biotech (PPBT) Stock Is Getting Hammered

Purple Biotech shares are trading lower by 28% during Tuesday's session. The company announced a $2.8 million offering.

Henry Khederian

Why Is Purple Biotech Stock Trading Higher On Monday?

Purple Biotech's Phase 2 trial of CM24 in metastatic PDAC patients showed improved survival rates, biomarker responses, and disease control outcomes.

Vandana Singh

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.40
Close	-
Volume / Avg.	4.74K / 109.24K
Day Range	$2.36 - $2.49
52 Wk Range	2.00 - 13.95
Market Cap	$6.59M
P/E Ratio	0.01
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.71%
Days to Cover	5.65

About Purple Biotech Ltd

Sector

Health Care

Industry

Pharmaceuticals

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to over...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Purple Biotech (PPBT) stock?

You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.

View our list of the best stock brokerages

Who are Purple Biotech (PPBT) competitors?

Other companies in Purple Biotech’s space includes: Cocrystal Pharma (NASDAQ:COCP), 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).

What is the forecast, or price target, for Purple Biotech (PPBT) stock?

Purple Biotech has a consensus price target of $15.75.

What is the current price for Purple Biotech (PPBT)?

The stock price for Purple Biotech (NASDAQ: PPBT) is $2.4899 last updated July 9, 2025 at 1:51 PM EDT.

Does Purple Biotech (PPBT) pay a dividend?

There are no upcoming dividends for Purple Biotech.

When is Purple Biotech (NASDAQ:PPBT) reporting earnings?

Purple Biotech’s Q2 earnings are confirmed for Friday, August 15, 2025.

Is Purple Biotech (PPBT) going to split?

There is no upcoming split for Purple Biotech.

What sector and industry does Purple Biotech (PPBT) operate in?

Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.